8-KThe WireRoutine
Reg FD Disclosure
Filed Sep 12, 2022 · 3y ago · Accession 0001193125-22-242461
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acumen Pharmaceuticals, Inc.
- Ticker
- ABOS
- CIK
- 1576885
- Form type
- 8-K
- Filing date
- Sep 12, 2022
- Report date
- Sep 12, 2022
- Document
- d267556d8k.htm
- Size
- 13.1 MB